Skip to main content
. 2021 May 11;17(5):e695–e702. doi: 10.1200/OP.20.01105

FIG 1.

FIG 1.

TTI for AA and EA OPSCC patients: (A) p16+ cohort and (B) p16− cohort. For each cohort, comparisons are shown for all patients and for early-stage and late-stage patients separately. AA, African American; EA, European American; OPSCC, oropharyngeal squamous cell carcinoma; TTI, time to treatment initiation.